Who can join
Studies open only to women
These studies list female participants only in their official record. Most other studies accept everyone regardless of sex.
573 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- Recruiting
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Uromedica
- Location
- Denver, CO + 3 other US sites
- Eligibility basics
- Ages 22+ · Women only
- Recruiting
Satavari and Ashoka for Menopause (SAM) Study
Vidya USA Corporation
- Location
- New Port Richey, FL
- Eligibility basics
- Ages 40–65 · Women only
- RecruitingPhase 4
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Janssen Research & Development, LLC
- Location
- Chapel Hill, NC
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 1/Phase 2
Opt-IVF for Personalized Medicine for Normal Responders
Urmila DIwekar
- Location
- West Palm Beach, FL
- Eligibility basics
- Ages 20–50 · Women only
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Phoenix, AZ + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- Recruiting
SAINT in Postpartum Depression (PPD)
Magnus Medical
- Location
- Worcester, MA + 3 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- La Jolla, CA + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
C. R. Bard
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22–70 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Encino, CA + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- Recruiting
Effectiveness and Safety of OviTex® PRS in Breast Reconstruction
Tela Bio Inc
- Location
- Tampa, FL + 2 other US sites
- Eligibility basics
- Ages 22–75 · Women only
- Recruiting
Randomized Evaluation of Natural Extract for Menopausal Wellness (RENEW)
India Glycols Ltd
- Location
- New Port Richey, FL
- Eligibility basics
- Ages 45–60 · Women only
- RecruitingPhase 1
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
UCB Biopharma SRL
- Location
- Santa Monica, CA + 5 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
Alnylam Pharmaceuticals
- Location
- Orange, CA + 5 other US sites
- Eligibility basics
- Ages 16–45 · Women only
- Recruiting
Thermoregulatory Physiology of Menopausal Hot Flashes
SRI International
- Location
- Menlo Park, CA
- Eligibility basics
- Ages 40–65 · Women only
- Recruiting
A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort
Signal Relief
- Location
- Meadowbrook, PA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 4
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
AstraZeneca
- Location
- Las Vegas, NV
- Eligibility basics
- Ages 18–130 · Women only
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Tucson, AZ + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- RecruitingPhase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Locus Biosciences
- Location
- Lancaster, CA + 11 other US sites
- Eligibility basics
- Ages 18–75 · Women only
- Recruiting
Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer
Kevin Doody
- Location
- Bedford, TX
- Eligibility basics
- Ages 18–35 · Women only
- Recruiting
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.
Mila Mend Inc.
- Location
- Los Angeles, CA
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie
- Location
- Los Angeles, CA + 14 other US sites
- Eligibility basics
- Ages 18+ · Women only
- Recruiting
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
FemPulse Corporation
- Location
- Beverly Hills, CA + 11 other US sites
- Eligibility basics
- Ages 21+ · Women only
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
- Location
- Phoenix, AZ + 30 other US sites
- Eligibility basics
- Ages 18–45 · Women only
Questions
If I fit this group, will I qualify?
Not necessarily. Age and sex limits are only the first filter. Each study has its own inclusion and exclusion criteria, and the research team decides at screening.
Where do these age and sex limits come from?
From the eligibility section of each study’s official ClinicalTrials.gov record. We don’t infer eligibility from anything else.